Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-04
DOI
10.3389/fphar.2020.01201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
- (2019) Felipe Tapia Cáceres et al. FASEB JOURNAL
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Extracellular matrix remodeling and cardiac fibrosis
- (2018) Li Li et al. MATRIX BIOLOGY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases
- (2018) Giacomo Emmi et al. Current Cardiology Reports
- NLRP3: A Novel Mediator in Cardiovascular Disease
- (2018) Wenyi Zhou et al. Journal of Immunology Research
- Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
- (2018) Nikolaos G. Frangogiannis MOLECULAR ASPECTS OF MEDICINE
- The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice
- (2018) Yuji Sogawa et al. PLoS One
- Charcot–Leyden Crystals Activate the NLRP3 Inflammasome and Cause IL-1β Inflammation in Human Macrophages
- (2018) Juan Francisco Rodríguez-Alcázar et al. JOURNAL OF IMMUNOLOGY
- Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling
- (2017) Lei Chen et al. Oncotarget
- ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
- (2017) Martina Kocan et al. Scientific Reports
- Inflammasomes are Differentially Expressed in Cardiovascular and other Tissues
- (2017) Y. Yin et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Anti-fibrotic actions of relaxin
- (2016) C S Samuel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation
- (2016) Pia Boza et al. MOLECULAR IMMUNOLOGY
- The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
- (2016) Chao Wang et al. Frontiers in Pharmacology
- Molecular Activation of the NLRP3 Inflammasome in Fibrosis: Common Threads Linking Divergent Fibrogenic Diseases
- (2015) Carol M. Artlett et al. ANTIOXIDANTS & REDOX SIGNALING
- Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease
- (2015) A. K. Schroer et al. JOURNAL OF CELL SCIENCE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins
- (2014) M Sarwar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
- (2014) Chrishan S. Samuel et al. HYPERTENSION
- Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
- (2013) Massimo Collino et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
- (2013) Chiara Sassoli et al. PLoS One
- Inflammasome-Independent NLRP3 Augments TGF- Signaling in Kidney Epithelium
- (2012) W. Wang et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
- (2012) Bryna Suet Man Chow et al. PLoS One
- The Minimal Active Structure of Human Relaxin-2
- (2011) Mohammed Akhter Hossain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- Macrophages: Master Regulators of Inflammation and Fibrosis
- (2010) Thomas Wynn et al. SEMINARS IN LIVER DISEASE
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
- (2009) Luigi Franchi et al. NATURE IMMUNOLOGY
- Cardiovascular effects of relaxin: from basic science to clinical therapy
- (2009) Xiao-Jun Du et al. Nature Reviews Cardiology
- Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
- (2008) Ishanee Mookerjee et al. FASEB JOURNAL
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now